Cargando…

Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

Belinostat is a hydroxamate class HDAC inhibitor that has demonstrated activity in peripheral T-cell lymphoma and is undergoing clinical trials for non-hematologic malignancies. We studied the pharmacokinetics of belinostat in hepatocellular carcinoma patients to determine the main pathway of metabo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ling-Zhi, Ramírez, Jacqueline, Yeo, Winnie, Chan, Mei-Yi Michelle, Thuya, Win-Lwin, Lau, Jie-Ying Amelia, Wan, Seow-Ching, Wong, Andrea Li-Ann, Zee, Ying-Kiat, Lim, Robert, Lee, Soo-Chin, Ho, Paul C., Lee, How-Sung, Chan, Anthony, Ansher, Sherry, Ratain, Mark J., Goh, Boon-Cher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559838/ https://www.ncbi.nlm.nih.gov/pubmed/23382909 http://dx.doi.org/10.1371/journal.pone.0054522

Ejemplares similares

Correction: Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients
por: Wang, Ling-Zhi, et al.
Publicado: (2014)

Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1
por: Wang, Lingzhi, et al.
Publicado: (2017)

Validation of a Rapid and Sensitive LC-MS/MS Method for Determination of Exemestane and Its Metabolites, 17β-Hydroxyexemestane and 17β-Hydroxyexemestane-17-O-β-D-Glucuronide: Application to Human Pharmacokinetics Study
por: Wang, Ling-Zhi, et al.
Publicado: (2015)

Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?
por: Sundararaghavan, Vikram L., et al.
Publicado: (2016)

Regioselective Glucuronidation of Diosmetin and Chrysoeriol by the Interplay of Glucuronidation and Transport in UGT1A9-Overexpressing HeLa Cells
por: Zeng, Xuejun, et al.
Publicado: (2016)

The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates
por: Järvinen, Erkka, et al.
Publicado: (2022)

Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants
por: Sun, Dongxiao, et al.
Publicado: (2006)

Effects of Andrographis paniculata and Orthosiphon stamineus Extracts on the Glucuronidation of 4-Methylumbelliferone in Human UGT Isoforms
por: Ismail, Sabariah, et al.
Publicado: (2010)

Drug‐drug interaction of atazanavir on UGT1A1‐mediated glucuronidation of molidustat in human
por: van der Mey, Dorina, et al.
Publicado: (2020)

Glucuronidation of [6]-shogaol, [8]-shogaol and [10]-shogaol by human tissues and expressed UGT enzymes: identification of UGT2B7 as the major contributor
por: He, Liangliang, et al.
Publicado: (2018)

Repurposing Belinostat for Alleviation of Atopic Dermatitis
por: Quah, Shan, et al.
Publicado: (2021)

Influence of OATP1B1 Function on the Disposition of Sorafenib‐β‐D‐Glucuronide
por: Bins, S, et al.
Publicado: (2017)

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer
por: Chan, Daniel, et al.
Publicado: (2013)

Identifying and applying a highly selective probe to simultaneously determine the O-glucuronidation activity of human UGT1A3 and UGT1A4
por: Jiang, Li, et al.
Publicado: (2015)

Commentary on: “Influence of OATP1B1 Function on the Disposition of Sorafenib‐β‐D‐Glucuronide”
por: Morrissey, KM, et al.
Publicado: (2017)

Pregnane-X-Receptor Controls Hepatic Glucuronidation During Pregnancy and Neonatal Development in Humanized UGT1 Mice
por: Chen, Shujuan, et al.
Publicado: (2012)

Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen
por: Mehboob, Huma, et al.
Publicado: (2017)

Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma
por: Hood, Katelyn, et al.
Publicado: (2016)

Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas
por: Allen, Pamela B, et al.
Publicado: (2018)

Belinostat exerts antitumor cytotoxicity through the ubiquitin‐proteasome pathway in lung squamous cell carcinoma
por: Kong, Li R., et al.
Publicado: (2017)

Searching for Tissue-Specific Expression Pattern-Linked Nucleotides of UGT1A Isoforms
por: Zhang, Wei, et al.
Publicado: (2007)

UGT1A6 Polymorphisms Modulated Lung Cancer Risk in a Chinese Population
por: Kua, Ley-Fang, et al.
Publicado: (2012)

Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9, and 2B7 and Impacts on Glucuronidation Activity
por: Yuan, Ling-Min, et al.
Publicado: (2016)

Monitoring the effect of belinostat in solid tumors by H4 acetylation
por: MARQUARD, LENA, et al.
Publicado: (2008)

Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
por: Bodiford, Andrew, et al.
Publicado: (2014)

New developments in the treatment of peripheral T-cell lymphoma – role of Belinostat
por: Reimer, Peter
Publicado: (2015)

Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patients
por: Belkhir, Leïla, et al.
Publicado: (2018)

Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development
por: Wang, Lingzhi, et al.
Publicado: (2016)

Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated Metabolite
por: Liu, Shuaibing, et al.
Publicado: (2021)

Preclinical efficacy of belinostat in combination with zidovudine in adult T-cell leukemia-lymphoma
por: Toomey, Ngoc, et al.
Publicado: (2015)

Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor
por: Yang, Zi-Zhao, et al.
Publicado: (2017)

FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway
por: Yeo, Mei Shi, et al.
Publicado: (2019)

A Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Nimbolide in Mouse Serum: Application to a Preclinical Pharmacokinetics Study
por: Wang, Lingzhi, et al.
Publicado: (2018)

Data on biosynthesis of BPAF glucuronide, enzyme kinetics of BPAF glucuronidation, and molecular modeling
por: Gramec Skledar, Darja, et al.
Publicado: (2018)

Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide
por: de Hoogd, Sjoerd, et al.
Publicado: (2017)

Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral t-cell lymphoma
por: Reimer, Peter, et al.
Publicado: (2013)

Ritonavir Interacts With Belinostat to Cause Endoplasmic Reticulum Stress and Histone Acetylation in Renal Cancer Cells
por: Isono, Makoto, et al.
Publicado: (2016)

Mutant Isocitrate Dehydrogenase 1 Expression Enhances Response of Gliomas to the Histone Deacetylase Inhibitor Belinostat
por: Chang, Chi-Ming, et al.
Publicado: (2023)

Glucuronidation of drugs in humanized UDP-glucuronosyltransferase 1 mice: Similarity with glucuronidation in human liver microsomes
por: Kutsuno, Yuki, et al.
Publicado: (2013)

Pharmacokinetics of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Terminally Ill Adult Patients
por: Franken, Linda G., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h3si7o3phfdf8gjhrc0vos76ng